Literature DB >> 17955177

Mammary stem cells and breast cancer.

G Molyneux1, J Regan, M J Smalley.   

Abstract

The mammary gland undergoes major developmental changes during puberty and pregnancy. It is thought that stem cells drive mammary gland development during puberty and are responsible for tissue maintenance as well as the major growth and remodelling that occurs with every pregnancy. The use of sophisticated cell separation procedures has facilitated the prospective isolation of mammary epithelial stem and differentiated cell subpopulations from the mouse mammary gland, while studies of primary human breast cancers have described sub-populations of tumourigenic cells capable of initiating tumour growth in immuno-compromised mice. These potential tumour 'stem cells' constitute an important therapeutic target population with respect to cancer therapy, as these are likely to be the cells which maintain tumour growth. Understanding the origin of these cells, their relationship to breast cancer subtypes, and how and why they differ from normal breast stem cells will lead to a revolution in tumour understanding, treatment and prevention. (Part of a Multi-author Review).

Entities:  

Mesh:

Year:  2007        PMID: 17955177     DOI: 10.1007/s00018-007-7391-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  21 in total

1.  Introduction: transplantation of the normal mammary gland: early evidence for a mammary stem cell.

Authors:  Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-09       Impact factor: 2.673

2.  Life stage differences in mammary gland gene expression profile in non-human primates.

Authors:  Petra Stute; Sonja Sielker; Charles E Wood; Thomas C Register; Cynthia J Lees; Fitriya N Dewi; J Koudy Williams; Janice D Wagner; Ulrich Stefenelli; J Mark Cline
Journal:  Breast Cancer Res Treat       Date:  2011-10-25       Impact factor: 4.872

3.  Differential remodeling of extracellular matrices by breast cancer initiating cells.

Authors:  Anju M Raja; Shuoyu Xu; Shuangmu Zhuo; Dean C S Tai; Wanxin Sun; Peter T C So; Roy E Welsch; Chien-Shing Chen; Hanry Yu
Journal:  J Biophotonics       Date:  2015-01-19       Impact factor: 3.207

Review 4.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

5.  Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.

Authors:  Sarah E Kelly; Altomare Di Benedetto; Adelaide Greco; Candace M Howard; Vincent E Sollars; Donald A Primerano; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

Review 6.  Mammary stem cell research in veterinary science: an update.

Authors:  Bizunesh M Borena; Leen Bussche; Christian Burvenich; Luc Duchateau; Gerlinde R Van de Walle
Journal:  Stem Cells Dev       Date:  2013-03-05       Impact factor: 3.272

7.  Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy.

Authors:  Brian W Booth; Corinne A Boulanger; Gilbert H Smith
Journal:  Breast Cancer Res       Date:  2008-10-24       Impact factor: 6.466

8.  Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.

Authors:  Kara L Britt; Howard Kendrick; Joseph L Regan; Gemma Molyneux; Fiona-Ann Magnay; Alan Ashworth; Matthew J Smalley
Journal:  Breast Cancer Res       Date:  2009-04-23       Impact factor: 6.466

9.  Epigenetics, Wnt signaling, and stem cells: the Pygo2 connection.

Authors:  Valerie Horsley
Journal:  J Cell Biol       Date:  2009-06-01       Impact factor: 10.539

10.  Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

Authors:  Jessica Kao; Keyan Salari; Melanie Bocanegra; Yoon-La Choi; Luc Girard; Jeet Gandhi; Kevin A Kwei; Tina Hernandez-Boussard; Pei Wang; Adi F Gazdar; John D Minna; Jonathan R Pollack
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.